D
Davide Brambilla
Researcher at Université de Montréal
Publications - 61
Citations - 3117
Davide Brambilla is an academic researcher from Université de Montréal. The author has contributed to research in topics: Medicine & Drug delivery. The author has an hindex of 21, co-authored 50 publications receiving 2499 citations. Previous affiliations of Davide Brambilla include École Polytechnique Fédérale de Lausanne & Université Paris-Saclay.
Papers
More filters
Journal ArticleDOI
Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery
TL;DR: This review will focus on the nature of the polymers involved in the preparation of targeted nanocarriers, the synthesis methods to achieve the desired macromolecular architecture, the selected coupling strategy, and the choice of the homing molecules (vitamins, hormones, peptides, proteins, etc.), as well as the various strategies to display them at the surface of nanoccarriers.
Journal ArticleDOI
Design, Functionalization Strategies and Biomedical Applications of Targeted Biodegradable/Biocompatible Polymer‐Based Nanocarriers for Drug Delivery
TL;DR: In this article, the design and functionalization strategies for multifunctional nanocarriers (e.g., nanoparticles, micelles, polymersomes) based on biodegradable/biocompatible polymers intended to be employed for active targeting and drug delivery are reviewed.
Journal ArticleDOI
Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues
Davide Brambilla,Benjamin Le Droumaguet,Julien Nicolas,S. Hossein Hashemi,Lin-Ping Wu,S. Moein Moghimi,Patrick Couvreur,Karine Andrieux +7 more
TL;DR: There are concerns regarding the initiation of possible NP-mediated adverse events in AD, thus demanding the use of precisely assembled nanoconstructs from biocompatible materials.
Journal ArticleDOI
Technology readiness and overcoming barriers to sustainably implement nanotechnology-enabled plant agriculture
Thilo Hofmann,Gregory V. Lowry,Subhasis Ghoshal,Nathalie Tufenkji,Davide Brambilla,John Dutcher,Leanne M. Gilbertson,Juan Pablo Giraldo,Joseph M. Kinsella,Markita P. Landry,Wess Lovell,Rafik Naccache,Mathews L. Paret,Joel A. Pedersen,Jason M. Unrine,Jason C. White,Kevin J. Wilkinson +16 more
TL;DR: The technological readiness is identified, the primary barriers to adopting nano-enabled technologies are addressed, and a roadmap to advance nanotechnology-enabled agriculture is proposed.
Journal ArticleDOI
PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer's disease.
Davide Brambilla,Romain Verpillot,Benjamin Le Droumaguet,Julien Nicolas,Myriam Taverna,Juraj Kóňa,Barbara Lettiero,S. Hossein Hashemi,Line De Kimpe,Mara Canovi,Marco Gobbi,Valérie Nicolas,Wiep Scheper,S. Moein Moghimi,Igor Tvaroška,Patrick Couvreur,Karine Andrieux +16 more
TL;DR: The results suggest that these engineered long-circulating NPs may have the ability to capture the toxic forms of the Aβ(1-42) peptide from the systemic circulation and potentially improve Alzheimer's disease condition through the proposed "sink effect".